Researchers have advanced a potential treatment for metaplastic breast cancer–the most aggressive subtype of triple negative breast cancer, into patients in just under four years.
Researchers have advanced a potential treatment for metaplastic breast cancer–the most aggressive subtype of triple negative breast cancer, into patients in just under four years.